SeVA is revolutionizing healthcare by improving delirium detection, reducing nursing workload, and enhancing patient outcomes.
In the United States, approximately 6 million patients suffer from Alzheimer’s dementia. This number is only going to grow in the future. Alzheimer’s is the leading cause of death in the United States, and out of the top causes of death, is the only one that cannot be prevented. Complicating the course of Alzheimer’s dementia in hospitalized patients is superimposed delirium, which is frequently missed by the care teams. Inouye et al. (2014), in their landmark LANCET study, were able to add a financial cost to this diagnosis and reported an estimated loss of $160 billion per year. A significant fraction of that lost revenue comes from patient’s prolonged stay in the hospital due to delirium and its complications. Each additional hospital day beyond the expected length of stay (defined by Medicare and commercial payers using the Diagnosis Related Group bundled payment methodology), adds to the hospital’s financial losses.
50 million people suffered from Alzheimer’s dementia worldwide in 2017. A new person develops dementia every 3 seconds. In general, the population that can benefit from the SeVA platform is huge, is growing, and threatens to drain the financial resources of both developed and developing countries. Beyond Alzheimer’s dementia, SeVA can also be utilized for delirium prevention in all hospitalized patients. In 2016, according to Center for Disease Control (CDC), an estimated 35 Million patients were hospitalized. Based on studies, one in every five patients in the hospital develops delirium, leading to an increased length of stay anywhere between 2-5 days. With these numbers in mind, SeVA has a cumulative potential of impacting and improving care for 7 million hospitalized patients each year in the United States, decreasing cumulative hospital length of stay by 14 million – 35 million patient days and therefore, having an enormous financial impact for both Healthcare systems and payers like Medicare. The average cost per hospital day in the United States is $2,346. As such cumulative cost-saving potential for SeVA is anywhere between $ 32 Billion to $ 80 Billion.
W
